Expertise in
2
conditions

Gary K. Hunter

5 Sheridan Street, 
Cairns, QLD, AU 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
5 Sheridan Street, 
Cairns, QLD, AU 

Overview

Gary Hunter practices practicing medicine in Cairns, Australia.

Mr. Hunter is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Stroke, Seizures, Cerebral Amyloid Angiopathy, Status Epilepticus, and Thrombectomy.

He is actively involved in clinical research, co-authoring 51 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

5 Sheridan Street, Cairns, QLD 4870, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

PROTEST Trial - PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury, a Double-blind Randomized Controlled Trial
PROTEST Trial - PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury, a Double-blind Randomized Controlled Trial
Enrollment Status: Recruiting
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Dalteparin
Study Phase: Phase 3
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Multicentre, Prospective Randomized Open Label, Blinded-endpoint (PROBE) Controlled Trial of Thrombolysis With Low Dose Tenecteplase (TNK-tPA) Versus Standard of Care in Minor Ischemic Stroke With Proven Acute Symptomatic Occlusion
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drugs: Tenecteplase, Antiplatelet Monotherapy
Study Phase: Phase 3
View 1 Less Clinical Trial

51 Total Publications

Cerebral Amyloid Angiopathy Imaging Markers, Radiological Boston Criteria, and Thrombolysis Outcomes in Ischemic Stroke.
Cerebral Amyloid Angiopathy Imaging Markers, Radiological Boston Criteria, and Thrombolysis Outcomes in Ischemic Stroke.
Journal: Stroke
Published: January 29, 2026

Frequently Asked Questions about Gary K. Hunter

Is Gary K. Hunter a top-rated expert for Thrombectomy?

MediFind is an objective health platform that identifies experts based on real-world data. Gary K. Hunter is classified as an Advanced expert for Thrombectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gary K. Hunter participate in research or clinical trials?

Yes. Gary K. Hunter has published 51 articles and abstracts on conditions like Thrombectomy. You can view a list of Gary K. Hunter's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hunter's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile